Noemi Horvath

2.8k total citations · 1 hit paper
60 papers, 1.7k citations indexed

About

Noemi Horvath is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Noemi Horvath has authored 60 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Hematology, 29 papers in Oncology and 27 papers in Molecular Biology. Recurrent topics in Noemi Horvath's work include Multiple Myeloma Research and Treatments (39 papers), Protein Degradation and Inhibitors (14 papers) and Cancer Treatment and Pharmacology (10 papers). Noemi Horvath is often cited by papers focused on Multiple Myeloma Research and Treatments (39 papers), Protein Degradation and Inhibitors (14 papers) and Cancer Treatment and Pharmacology (10 papers). Noemi Horvath collaborates with scholars based in Australia, United States and New Zealand. Noemi Horvath's co-authors include Andrew Spencer, H. Miles Prince, Luen Bik To, Andrew C.W. Zannettino, Pieter Sonneveld, Liang Xiu, Trilok Parekh, Roman Hájek, Jesús F. San Miguel and Arnon Nagler and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Noemi Horvath

57 papers receiving 1.7k citations

Hit Papers

Randomized Phase III Study of Pegylated Liposomal Doxorub... 2007 2026 2013 2019 2007 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Randomized Phase III Study of Pegylated Liposomal Doxorubicin Plus Bortezomib Compared With Bortezomib Alone in Relapsed or Refractory Multiple Myeloma: Combination Therapy Improves Time to Progression
    2007 505 citations Pieter Sonneveld, Andrew Spencer et al. profile →

Peers

Noemi Horvath
Thomas Moehler Germany
Carolina Schinke United States
Sharmilan Thanendrarajan United States
Sylvia Feyler United Kingdom
Laurent Voillat France
Nuria Navarro-Coy United Kingdom
Christophe Ravoet Belgium
Peter Duggan Canada
Rik Schots Belgium
José C. Cruz United States
Thomas Moehler Germany
Noemi Horvath
Citations per year, relative to Noemi Horvath Noemi Horvath (= 1×) peers Thomas Moehler

Countries citing papers authored by Noemi Horvath

Since Specialization
Citations

This map shows the geographic impact of Noemi Horvath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noemi Horvath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noemi Horvath more than expected).

Fields of papers citing papers by Noemi Horvath

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noemi Horvath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noemi Horvath. The network helps show where Noemi Horvath may publish in the future.

Co-authorship network of co-authors of Noemi Horvath

This figure shows the co-authorship network connecting the top 25 collaborators of Noemi Horvath. A scholar is included among the top collaborators of Noemi Horvath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noemi Horvath. Noemi Horvath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Panagopoulos, Vasilios, Melissa Cantley, D. Hewett, et al.. (2025). Age-related mesenchymal stromal cell senescence is associated with progression from MGUS to multiple myeloma. Leukemia. 39(6). 1464–1475. 3 indexed citations
2.
3.
Turner, Robert, Hang Quach, Noemi Horvath, et al.. (2023). Response adaptive salvage with KTd and ASCT for functional high‐risk multiple myeloma—The Australasian Leukemia and Lymphoma Group (ALLG) MM17 Trial. British Journal of Haematology. 202(3). 530–538. 3 indexed citations
4.
Horvath, Noemi, et al.. (2023). Lenalidomide Desensitization for Delayed Cutaneous Reaction: A Case Series and Review of the Literature. The Journal of Allergy and Clinical Immunology In Practice. 11(5). 1503–1508.
5.
Ho, P. Joy, Elizabeth Moore, Zoe McQuilten, et al.. (2019). Renal Impairment at Diagnosis in Myeloma: Patient Characteristics, Treatment, and Impact on Outcomes. Results From the Australia and New Zealand Myeloma and Related Diseases Registry. Clinical Lymphoma Myeloma & Leukemia. 19(8). e415–e424. 17 indexed citations
6.
7.
Bergin, Krystal, Elizabeth Moore, Zoe McQuilten, et al.. (2016). Design and development of the Australian and New Zealand (ANZ) myeloma and related diseases registry. BMC Medical Research Methodology. 16(1). 151–151. 22 indexed citations
8.
Weber, N, Peter Mollee, Ross Brown, et al.. (2014). Management of systemic AL amyloidosis: recommendations of the Myeloma Foundation of Australia Medical and Scientific Advisory Group. Internal Medicine Journal. 45(4). 371–382. 19 indexed citations
9.
Ling, Silvia, Alberto Catalano, Harry Iland, et al.. (2011). Response of myeloma to the proteasome inhibitor bortezomib is correlated with the unfolded protein response regulator XBP-1. Haematologica. 97(1). 64–72. 103 indexed citations
10.
Dawson, Mark A., Stephen Opat, Yamna Taouk, et al.. (2009). Clinical and Immunohistochemical Features Associated with a Response to Bortezomib in Patients with Multiple Myeloma. Clinical Cancer Research. 15(2). 714–722. 25 indexed citations
11.
Vij, Ravi, Noemi Horvath, Andrew Spencer, et al.. (2009). An open‐label, phase 2 trial of denosumab in the treatment of relapsed or plateau‐phase multiple myeloma. American Journal of Hematology. 84(10). 650–656. 72 indexed citations
12.
Keefe, Dorothy, et al.. (2006). Palifermin for oral mucositis in the high-dose chemotherapy and stem cell transplant setting: the Royal Adelaide Hospital Cancer Centre experience. Supportive Care in Cancer. 14(6). 580–582. 23 indexed citations
13.
Wolf, Max, Mark Bentley, Paula Marlton, et al.. (2006). Pegfilgrastim to support CHOP-14 in elderly patients with non-Hodgkin's lymphoma. Leukemia & lymphoma. 47(11). 2344–2350. 20 indexed citations
14.
Horvath, Noemi, Uwe Hahn, D. Joshua, et al.. (2004). Long‐term follow up of sequential mobilisation and autologous transplantation with CD34‐selected cells in multiple myeloma: a multimodality approach. Internal Medicine Journal. 34(4). 167–175. 3 indexed citations
15.
Farrugia, Amanda, Gerald J. Atkins, Luen Bik To, et al.. (2003). Receptor activator of nuclear factor-kappaB ligand expression by human myeloma cells mediates osteoclast formation in vitro and correlates with bone destruction in vivo.. PubMed. 63(17). 5438–45. 177 indexed citations
16.
Bardy, Peter, et al.. (2002). Isolated cardiac recurrence of acute lymphoblastic leukemia characterized by t(11;19) two years after unrelated allogeneic bone marrow transplantation. Cancer Genetics and Cytogenetics. 137(2). 146–149. 9 indexed citations
17.
Borg, Martin, Timothy P. Hughes, Noemi Horvath, Michael Rice, & Anthony Thomas. (2002). Renal toxicity after total body irradiation. International Journal of Radiation Oncology*Biology*Physics. 54(4). 1165–1173. 37 indexed citations
18.
Dyson, P., Noemi Horvath, D. Joshua, et al.. (2000). CD34+ selection of autologous peripheral blood stem cells for transplantation following sequential cycles of high-dose therapy and mobilisation in multiple myeloma. Bone Marrow Transplantation. 25(11). 1175–1184. 22 indexed citations
19.
20.
Palkovits, Miklós, et al.. (1961). [The effect of the peroral antidiabetic 1-sulfanilyl-3-n-butylurea on the function and glycogen formation of liver cells].. PubMed. 11. 94–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas Moehler Breakdown of academic impact, for papers by Carolina Schinke Breakdown of academic impact, for papers by Sharmilan Thanendrarajan Breakdown of academic impact, for papers by Sylvia Feyler Breakdown of academic impact, for papers by Laurent Voillat Breakdown of academic impact, for papers by Nuria Navarro-Coy Breakdown of academic impact, for papers by Christophe Ravoet Breakdown of academic impact, for papers by Peter Duggan Breakdown of academic impact, for papers by Rik Schots Breakdown of academic impact, for papers by José C. Cruz
Rankless by CCL
2026